KORU Medical Systems Inc. (KRMD)
(Delayed Data from NSDQ)
$2.69 USD
+0.12 (4.67%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.68 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for KORU Medical Systems Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 11 | 17 | 25 | 27 | 6 |
Receivables | 4 | 5 | 4 | 3 | 3 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 6 | 6 | 7 | 2 |
Other Current Assets | 1 | 1 | 2 | 1 | 0 |
Total Current Assets | 20 | 30 | 37 | 38 | 12 |
Net Property & Equipment | 4 | 4 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 4 | 2 | 0 | 0 |
Intangibles | 1 | 1 | 1 | 1 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 28 | 42 | 41 | 40 | 14 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 1 | 0 | 0 |
Accounts Payable | 1 | 2 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2 | 3 | 3 | 3 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4 | 7 | 5 | 4 | 2 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 8 | 11 | 5 | 4 | 3 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 47 | 44 | 41 | 36 | 6 |
Retained Earnings | -23 | -10 | -1 | 4 | 5 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 4 | 4 | 4 | 4 | 0 |
Total Shareholder's Equity | 20 | 31 | 37 | 36 | 11 |
Total Liabilities & Shareholder's Equity | 28 | 42 | 41 | 40 | 14 |
Total Common Equity | 20 | 31 | 37 | 36 | 11 |
Shares Outstanding | 45.60 | 45.20 | 44.50 | 43.90 | 39.50 |
Book Value Per Share | 0.45 | 0.69 | 0.82 | 0.82 | 0.28 |
Fiscal Year End for KORU Medical Systems Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 10 | 11 | 11 | 11 | 12 |
Receivables | 6 | 5 | 4 | 5 | 5 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 3 | 3 | 5 | 5 |
Other Current Assets | 0 | 1 | 1 | 1 | 1 |
Total Current Assets | 19 | 19 | 20 | 22 | 23 |
Net Property & Equipment | 4 | 4 | 4 | 4 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 5 | 5 |
Intangibles | 1 | 1 | 1 | 1 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 27 | 28 | 28 | 35 | 36 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 1 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 2 | 2 | 2 | 2 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 1 | 1 | 0 |
Total Current Liabilities | 5 | 5 | 4 | 4 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 9 | 8 | 8 | 8 | 8 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 48 | 48 | 47 | 47 | 46 |
Retained Earnings | -26 | -25 | -23 | -16 | -14 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 4 | 4 | 4 | 4 | 4 |
Total Shareholder's Equity | 19 | 19 | 20 | 27 | 28 |
Total Liabilities & Shareholder's Equity | 27 | 28 | 28 | 35 | 36 |
Total Common Equity | 19 | 19 | 20 | 27 | 28 |
Shares Outstanding | 45.70 | 45.70 | 45.60 | 45.60 | 45.60 |
Book Value Per Share | 0.41 | 0.42 | 0.45 | 0.60 | 0.62 |